Radius health & menarini group provide elacestrant update

Radius health & menarini group provide elacestrant update.radius health inc - target enrollment milestone reached in phase 3 emerald study.radius health inc - life cycle planning advancing in parallel with current phase 3 monotherapy program.radius health inc - idmc recommended that trial continues to advance in an unmodified manner.radius health inc - analysis of primary endpoint of study is anticipated will take place in second half of 2021.
RDUS Ratings Summary
RDUS Quant Ranking